Donald J. Hayden Jr - Dec 29, 2022 Form 4 Insider Report for Theseus Pharmaceuticals, Inc. (THRX)

Role: Director
Signature: /s/ Bradford Dahms - Attorney-in-Fact
Stock symbol: THRX
Transactions as of: Dec 29, 2022
Transactions value $: $49,989
Form type: 4
Date filed: 1/3/2023, 06:05 AM
Previous filing: May 18, 2022
Next filing: Jun 13, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	THRX	Common Stock	Purchase	$500	+100		$5.00	100	Dec 29, 2022	Direct
transaction	THRX	Common Stock	Purchase	$49.5K	+9.9K	+9900%	$5.00	10K	Dec 30, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $4.98 to $5.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Content

The price reported is a weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $4.98 to $5.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.